Prucalopride succinate
- Molecular formula
- C23H34ClN5O3
- CAS Number
- 179474-81-8
- IUPAC Name
- diethyl-[2-[5-nitro-2-(2-pyrrolidin-1-ylethyl)benzimidazol-1-yl]ethyl]ammonium;chloride
- Molecular Weight
- 367.88g/mol
- Melting Point
- (Celsius)
- Boiling Point
- (Celsius)
- Density
- 1.4000g/cm3
- Appearance
- may vary depending on the purity and specific formulation.
- Synonyms
- Benzimidazole, 1-(2-(diethylamino)ethyl)-5-nitro-2-(2-(pyrrolidin-1-yl)ethyl)-, hydrochloride
Identification
Interesting Facts About Diethyl-[2-[5-nitro-2-(2-pyrrolidin-1-ylethyl)benzimidazol-1-yl]ethyl]ammonium;chloride
Diethyl-[2-[5-nitro-2-(2-pyrrolidin-1-ylethyl)benzimidazol-1-yl]ethyl]ammonium;chloride, a compound rich in biological significance, is gaining attention in various fields, especially pharmacology and medicinal chemistry. Here are some fascinating aspects of this compound:
- Pharmacological Potential: The presence of the benzimidazole moiety is notable as these structures are often linked to pharmacological activity, including anti-parasitic and anti-cancer properties.
- Design Features: The incorporation of a nitro group and the pyrrolidine ring structure suggests enhanced interactions with biological targets, which can influence the compound’s efficacy as a drug.
- Stability and Solubility: As a quaternary ammonium salt, where the ammonium ion is balanced by chloride, this compound typically exhibits increased stability and favorable solubility in aqueous solutions, making it suitable for various applications.
- Research Applications: Scientists are interested in the use of this compound as a potential therapeutic agent. Ongoing research focuses on understanding its mechanisms of action and exploring its capability to inhibit specific biological pathways.
- Structure Activity Relationship (SAR): The structural variations in this compound provide an opportunity to investigate how modifications can enhance its pharmacological profile, paving the way for the development of novel therapeutics.
Quoting a renowned chemist, “The beauty of compound design lies in the endless possibilities that structure can unveil.” This compound exemplifies that beauty through its unique arrangement of functional groups and potential applications.
In conclusion, Diethyl-[2-[5-nitro-2-(2-pyrrolidin-1-ylethyl)benzimidazol-1-yl]ethyl]ammonium;chloride stands as a prime example of innovation in drug design, inviting further exploration and discovery in the realm of chemistry and medicine.